Hemodynamic Results of Perorally Administered Converting Enzme Inhibitors in Congestive Heart Failure

Area of Science:

• Cardiology
• Pharmacology

Background:

• Congestive heart failure (CHF) management often involves managing the renin-angiotensin system.
• Loop diuretics are commonly used in CHF but can lead to hypovolemia.

Purpose of the Study:

• To evaluate the acute hemodynamic effects of captopril and enalapril in CHF patients.
• To assess the safety and tolerability of initiating ACE inhibitor therapy in this population.

Main Methods:

• Acute hemodynamic assessment in 16 NYHA class III CHF patients.
• Administration of captopril (8 patients) and enalapril (8 patients).
• Observation of patient response during initiation of maintenance therapy.

Main Results:

• Significant interindividual variability in hemodynamic response observed.
• Average increases in cardiac output and decreases in filling pressures aligned with existing literature.
• One patient in the captopril group required heart transplantation; one in the enalapril group experienced arrhythmias and hypertension.

Conclusions:

• ACE inhibitor therapy in CHF patients requires careful consideration of potential hypovolemia.
• Excessive loop diuretic use may predispose patients to drug-induced hypotension when initiating ACE inhibitors.
• The renin-angiotensin system's activation warrants attention in CHF management with ACE inhibitors.